SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: progenics

No earlier versions found for this Subject.


Return to progenics
 
Forbes just ran a positive article on this company, but I don't see
a thread on it...someone correct me if I am wrong!

They are trying to make cancer vaccines and HIV treatments, and they
have one vaccine in phase III trials (that is the last phase, no?)
Another one is in phase II. Looks from Yahoo like they are already
profitable thanks to payments from Bristol-Meyers Squibb.

IPO 11/97, float only 2M shares. They just bounced up 20%, no doubt
due to the article.

Comments?

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News